ACON

MKT CAP:$2M

Aclarion, Inc.

Market Cap

$2M

Healthcare·Medical - Healthcare Information Services·🇺🇸 United States·NASDAQ

Healthcare·Medical·🇺🇸·NASDAQ

Stock Price

$3.73-$1.25 (-25.10%)

Apr 22, 2026

Company Details

Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States. It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the...

CEO

Brent Ness

IPO Date

Apr 22, 2022

Website

www.aclarion.com

Key Metrics TTM

Revenue

$67.5K

+36.9% YoY

Net Income

-$7M

EPS (Diluted)

-$1,602.94

Free Cash Flow

-$7M

Revenue / Share

$0.12

Gross Margin

-7.8%

Operating Margin

-10173.7%

Net Margin

-10867.8%

FCF Margin

-9672.6%

P/S

26.1x

P/E

—

Earnings Reports

Q3 2025

Nov 12, 2025

$18.9K+31.5%EPS -$2.93

Q2 2025

Aug 14, 2025

$19.3K+76.1%EPS -$2.75

Q1 2025

May 15, 2025

$19.0K+87.8%EPS -$9.32

FY 2024

Apr 8, 2025

$45.7K-39.4%EPS -$7,480.22

Q4 2024

Apr 8, 2025

$10.2K-25.8%EPS -$1,587.94

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q2 21	$25.6K	$5.3K	-$626.6K
Q3 21	$10.9K	-$5.2K	-$797.3K
Q4 21	$12.0K	-$4.2K	-$1M
Q1 22	$9.0K	-$7.7K	-$773.1K
Q3 22	$18.2K	$1.2K	-$2M
Q1 23	$25.5K	$8.0K	-$1M
Q2 23	$17.1K	-$2.2K	-$1M
Q3 23	$19.1K	-$493	-$1M
Q4 23	$13.8K	-$5.6K	-$1M
Q1 24	$10.1K	-$9.4K	-$1M
Q2 24	$11.0K	-$12.3K	-$1M
Q3 24	$14.4K	-$6.9K	-$1M
Q4 24	$10.2K	-$10.3K	-$2M
Q1 25	$19.0K	-$4.5K	-$1M
Q2 25	$19.3K	$5.1K	-$2M
Q3 25	$18.9K	$4.4K	-$2M

Valuation

Quarter	P/S	P/E
Q2 21	285.9x	—
Q3 21	341.9x	—
Q4 21	330.5x	—
Q1 22	346.6x	—
Q3 22	133.4x	—
Q1 23	76.5x	—
Q2 23	85.0x	—
Q3 23	67.6x	—
Q4 23	259.5x	—
Q1 24	5.6x	—
Q2 24	5.1x	—
Q3 24	4.3x	—
Q4 24	3.7x	—
Q1 25	115.2x	—
Q2 25	69.7x	—
Q3 25	65.8x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q2 21	-$492.2K	-$543.4K
Q3 21	-$829.0K	-$829.0K
Q4 21	-$574.8K	-$591.8K
Q1 22	-$309.4K	-$392.1K
Q3 22	-$1M	-$1M
Q1 23	-$1M	-$1M
Q2 23	-$947.5K	-$1M
Q3 23	-$1M	-$1M
Q4 23	-$733.8K	-$767.7K
Q1 24	-$2M	-$2M
Q2 24	-$1M	$0
Q3 24	-$1M	-$1M
Q4 24	-$899.5K	-$904.6K
Q1 25	-$3M	-$3M
Q2 25	-$2M	-$2M
Q3 25	-$1M	-$1M

Capital Expenditures

Quarter	CapEx
Q2 21	$51.2K
Q3 21	$1
Q4 21	$17.0K
Q1 22	$82.7K
Q3 22	$38.7K
Q1 23	$11.7K
Q2 23	$60.9K
Q3 23	$2
Q4 23	$33.9K
Q1 24	$63.7K
Q2 24	$1M
Q3 24	$103.7K
Q4 24	$5.1K
Q1 25	$78.3K
Q2 25	$478
Q3 25	$7.3K

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q2 21	+212.3%	-23.8%
Q3 21	-51.2%	-65.6%
Q4 21	+20.1%	+132.9%
Q1 22	-23.7%	+65.6%
Q3 22	-28.9%	+153.2%
Q1 23	+134.4%	+49.3%
Q2 23	+42.5%	+31.7%
Q3 23	+111.2%	+51.0%
Q4 23	-24.3%	-31.0%
Q1 24	-60.3%	+6.5%
Q2 24	-35.7%	-19.4%
Q3 24	-24.4%	+10.9%
Q4 24	-25.8%	+59.3%
Q1 25	+87.8%	+17.5%
Q2 25	+76.1%	+53.1%
Q3 25	+31.5%	+41.2%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q2 21	$4.7K	18.5%
Q3 21	$0	0.0%
Q4 21	$84.0K	701.5%
Q1 22	$23.1K	256.2%
Q3 22	$326.2K	1790.1%
Q1 23	$82.5K	324.0%
Q2 23	$136.6K	800.3%
Q3 23	$0	0.0%
Q4 23	$99.5K	721.4%
Q1 24	$85.8K	848.6%
Q2 24	$0	0.0%
Q3 24	$74.7K	518.5%
Q4 24	$0	0.0%
Q1 25	$55.9K	294.3%
Q2 25	$28.4K	146.8%
Q3 25	$16.7K	88.4%

OpEx Breakdown

Quarter	R&D	G&A	S&M
Q2 21	$162.7K	$404.3K	$65.0K
Q3 21	$275.3K	$438.4K	$78.4K
Q4 21	$182.1K	$760.7K	$121.6K
Q1 22	$204.8K	$491.3K	$69.3K
Q3 22	$291.0K	$1M	$159.4K
Q1 23	$204.4K	$807.6K	$177.3K
Q2 23	$250.0K	$946.2K	$207.8K
Q3 23	$198.3K	$770.5K	$192.9K
Q4 23	$220.7K	$721.0K	$179.0K
Q1 24	$239.0K	$845.8K	$181.1K
Q2 24	$202.1K	$696.1K	$225.0K
Q3 24	$195.8K	$860.5K	$232.8K
Q4 24	$251.8K	$1M	$337.7K
Q1 25	$198.2K	$986.7K	$302.6K
Q2 25	$270.4K	$1M	$343.8K
Q3 25	$302.0K	$900.9K	$632.4K

War Chest

Quarter	Cash	Short-term Investments	Total
Q4 21	$432.5K	$0	$432.5K
Q1 22	$50.4K	$0	$50.4K
Q2 22	$4M	$0	$4M
Q3 22	$3M	$0	$3M
Q4 22	$1M	$0	$1M
Q1 23	$448.0K	$0	$448.0K
Q2 23	$604.5K	$0	$604.5K
Q3 23	$161.4K	$0	$161.4K
Q4 23	$1M	$0	$1M
Q1 24	$2M	$0	$2M
Q2 24	$1M	$50.0K	$1M
Q3 24	$1M	$0	$1M
Q4 24	$453.7K	$0	$453.7K
Q1 25	$15M	$0	$15M
Q2 25	$13M	$39.0K	$13M
Q3 25	$11M	$0	$11M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q2 21	6	-88.9%	-87.8%
Q3 21	6	0.0%	-87.8%
Q4 21	49	+716.7%	0.0%
Q1 22	54	+10.2%	0.0%
Q3 22	54	0.0%	+800.0%
Q1 23	54	0.0%	+800.0%
Q2 23	57	+5.6%	+16.3%
Q3 23	58	+1.8%	+7.4%
Q4 23	91	+56.9%	+68.5%
Q1 24	601	+560.4%	+1013.0%
Q2 24	908	+51.1%	+1493.0%
Q3 24	1K	+14.9%	+1698.3%
Q4 24	1K	+22.9%	+1308.8%
Q1 25	219K	+17011.2%	+36400.2%
Q2 25	582K	+165.5%	+64037.8%
Q3 25	582K	0.0%	+55736.1%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q2 21	—	—
Q3 21	—	—
Q4 21	—	—
Q1 22	—	—
Q3 22	—	—
Q1 23	$3.6K	7
Q2 23	$2.4K	7
Q3 23	$2.7K	7
Q4 23	$2.3K	6
Q1 24	$1.7K	6
Q2 24	$1.8K	6
Q3 24	$2.4K	6
Q4 24	$1.7K	6
Q1 25	$3.2K	6
Q2 25	$3.2K	6
Q3 25	$3.2K	6

Revenue / Employee